The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage - PubMed (original) (raw)
. 2006 Dec;27(12):2469-74.
doi: 10.1093/carcin/bgl114. Epub 2006 Jul 8.
Affiliations
- PMID: 16829685
- DOI: 10.1093/carcin/bgl114
The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage
Reto Brem et al. Carcinogenesis. 2006 Dec.
Abstract
X-ray repair cross-complementing 1 (XRCC1) is required for single-strand break repair in human cells and several polymorphisms in this gene have been implicated in cancer risk and clinical prognostic factors. We examined the frequency of the 5'-untranslated region (5'-UTR) variant -77T-->C (rs 3213235) in 247 French breast cancer (BC) patients, 66 of whom were adverse radiotherapy responders, and 380 controls and determined the haplotypes based on this and the previously genotyped variants Arg194Trp, Arg280His and Arg399Gln. The -77T-->C variant alone showed no significant association with BC risk or therapeutic radiation sensitivity. The H5 haplotype (variant allele codon 280, wild-type allele other positions) was associated with increased BC risk [odds ratio (OR), 1.90; 95% confidence interval (CI), 1.12-3.23] and the H3 haplotype (wild-type allele all four positions) was inversely associated with therapeutic radiation sensitivity compared with the reference group (H1 haplotype, -77C, wild-type allele codons 194, 280, 399) (OR, 0.39; 95% CI, 0.16-0.92). However given that the global tests for association were not significant these results should be interpreted carefully. Lymphoblastoid cell lines heterozygous for the H1/H3 haplotypes had a significantly higher cell survival (P=0.04) after exposure to ionising radiation (IR) than those with the H1/H1 haplotypes, in agreement with the association study. However no haplotype-specific differences in XRCC1 expression or cell cycle progression were noted in the 24 h following IR exposure. These results suggest that the -77T-->C genotype or another variant in linkage disequilibrium influences the cellular response to DNA damage, although the underlying molecular mechanisms remain to be established.
Similar articles
- Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy.
Moullan N, Cox DG, Angèle S, Romestaing P, Gérard JP, Hall J. Moullan N, et al. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1168-74. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652276 - A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer.
Liu L, Yuan P, Liu L, Wu C, Zhang X, Guo H, Zhong R, Xu Y, Wu J, Duan S, Rui R, Wu T, Nie S, Miao X, Lin D. Liu L, et al. Breast Cancer Res Treat. 2011 Jan;125(2):479-87. doi: 10.1007/s10549-010-0959-z. Epub 2010 Jun 13. Breast Cancer Res Treat. 2011. PMID: 20549339 - A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W. Shu XO, et al. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1462-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693738 - XRCC1 polymorphism and lung cancer risk.
Schneider J, Classen V, Helmig S. Schneider J, et al. Expert Rev Mol Diagn. 2008 Nov;8(6):761-80. doi: 10.1586/14737159.8.6.761. Expert Rev Mol Diagn. 2008. PMID: 18999926 Review. - XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.
Hu Z, Ma H, Chen F, Wei Q, Shen H. Hu Z, et al. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1810-8. doi: 10.1158/1055-9965.EPI-04-0793. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030121 Review.
Cited by
- Predictive value of single nucleotide polymorphisms in XRCC1 for radiation-induced normal tissue toxicity.
Zhao J, Zhi Z, Zhang M, Li Q, Li J, Wang X, Ma C. Zhao J, et al. Onco Targets Ther. 2018 Jul 6;11:3901-3918. doi: 10.2147/OTT.S156175. eCollection 2018. Onco Targets Ther. 2018. PMID: 30013370 Free PMC article. - Among 45 variants in 11 genes, HDM2 promoter polymorphisms emerge as new candidate biomarker associated with radiation toxicity.
Alsbeih G, El-Sebaie M, Al-Rajhi N, Al-Harbi N, Al-Hadyan K, Al-Qahtani S, Alsubael M, Al-Shabanah M, Moftah B. Alsbeih G, et al. 3 Biotech. 2014 Apr;4(2):137-148. doi: 10.1007/s13205-013-0135-3. Epub 2013 Apr 26. 3 Biotech. 2014. PMID: 28324443 Free PMC article. - Association of -77T>C and Arg194trp polymorphisms of XRCC1 with risk of coronary artery diseases in Iranian population.
Pahlavanneshan S, Ahmadi A, Boroumand M, Sadeghian S, Behmanesh M. Pahlavanneshan S, et al. Iran J Basic Med Sci. 2016 Feb;19(2):194-200. Iran J Basic Med Sci. 2016. PMID: 27081465 Free PMC article. - Polymorphisms in base excision repair genes: Breast cancer risk and individual radiosensitivity.
Patrono C, Sterpone S, Testa A, Cozzi R. Patrono C, et al. World J Clin Oncol. 2014 Dec 10;5(5):874-82. doi: 10.5306/wjco.v5.i5.874. World J Clin Oncol. 2014. PMID: 25493225 Free PMC article. Review. - Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation-induced fibrosis in patients with nasopharyngeal carcinoma.
Cheuk IW, Yip SP, Kwong DL, Wu VW. Cheuk IW, et al. Mol Clin Oncol. 2014 Jul;2(4):553-558. doi: 10.3892/mco.2014.276. Epub 2014 Apr 14. Mol Clin Oncol. 2014. PMID: 24940494 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical